3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
6
Gastrointestinal
6
Endocrine
6
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
1012
Lung Neoplasms
769
Small Cell Lung Carcinoma
159
Breast Neoplasms
73
Adenocarcinoma of Lung
68
Neoplasms
67
Colorectal Neoplasms
50
NSCLC
49
Melanoma
48
Stomach Neoplasms
46
Pleural Effusion, Malignant
46
Pancreatic Neoplasms
45
Brain Neoplasms
42
Mesothelioma, Malignant
41
Ovarian Neoplasms
32
Prostatic Neoplasms
31
Neoplasm Metastasis
31
Head and Neck Neoplasms
30
Mesothelioma
28
Esophageal Neoplasms
27
Carcinoma, Renal Cell
24
Carcinoma
24
Urinary Bladder Neoplasms
23
Lung Diseases
22
Colonic Neoplasms
22
Thoracic Neoplasms
19
Liver Neoplasms
19
Thymoma
18
Carcinoma, Hepatocellular
18
Pleural Effusion
17
Interventions
regorafenib
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gastro-enteropancreatic neuroendocrine tumor
×
Thoracic
×
Clear all
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled